Cargando…
The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
Here we show that human papillomavirus (HPV) E6 and E7 oncoproteins induce hWAPL expression. In addition, small interfering RNA (siRNA) of hWAPL suppressed the growth of tumours derived from SiHa cells in nude mice. Thus, hWAPL may be one of the effective targets of uterine cervical cancer therapy.
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361835/ https://www.ncbi.nlm.nih.gov/pubmed/15655544 http://dx.doi.org/10.1038/sj.bjc.6602329 |
_version_ | 1782153311761203200 |
---|---|
author | Kuroda, M Kiyono, T Oikawa, K Yoshida, K Mukai, K |
author_facet | Kuroda, M Kiyono, T Oikawa, K Yoshida, K Mukai, K |
author_sort | Kuroda, M |
collection | PubMed |
description | Here we show that human papillomavirus (HPV) E6 and E7 oncoproteins induce hWAPL expression. In addition, small interfering RNA (siRNA) of hWAPL suppressed the growth of tumours derived from SiHa cells in nude mice. Thus, hWAPL may be one of the effective targets of uterine cervical cancer therapy. |
format | Text |
id | pubmed-2361835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23618352009-09-10 The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target Kuroda, M Kiyono, T Oikawa, K Yoshida, K Mukai, K Br J Cancer Short Communication Here we show that human papillomavirus (HPV) E6 and E7 oncoproteins induce hWAPL expression. In addition, small interfering RNA (siRNA) of hWAPL suppressed the growth of tumours derived from SiHa cells in nude mice. Thus, hWAPL may be one of the effective targets of uterine cervical cancer therapy. Nature Publishing Group 2005-01-31 2005-01-11 /pmc/articles/PMC2361835/ /pubmed/15655544 http://dx.doi.org/10.1038/sj.bjc.6602329 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Short Communication Kuroda, M Kiyono, T Oikawa, K Yoshida, K Mukai, K The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target |
title | The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target |
title_full | The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target |
title_fullStr | The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target |
title_full_unstemmed | The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target |
title_short | The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target |
title_sort | human papillomavirus e6 and e7 inducible oncogene, hwapl, exhibits potential as a therapeutic target |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361835/ https://www.ncbi.nlm.nih.gov/pubmed/15655544 http://dx.doi.org/10.1038/sj.bjc.6602329 |
work_keys_str_mv | AT kurodam thehumanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT kiyonot thehumanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT oikawak thehumanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT yoshidak thehumanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT mukaik thehumanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT kurodam humanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT kiyonot humanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT oikawak humanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT yoshidak humanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget AT mukaik humanpapillomaviruse6ande7inducibleoncogenehwaplexhibitspotentialasatherapeutictarget |